425 Publications (Page 7 of 17)
2011
Targets for AD treatment: conflicting messages from γ-secretase inhibitors.Sambamurti, Kumar⋅Greig, Nigel H⋅Utsuki, Tadanobu⋅Barnwell, Eliza L⋅Sharma, Ekta⋅Mazell, Cheryl⋅Bhat, Narayan R⋅Kindy, Mark S⋅Lahiri, Debomoy K and Pappolla, Miguel AJournal of neurochemistry, vol. 117, (no. 3), pp. 359-74, 2011/May.
| Journal Article
The "aged garlic extract:" (AGE) and one of its active ingredients S-allyl-L-cysteine (SAC) as potential preventive and therapeutic agents for Alzheimer's disease (AD).Ray, B⋅Chauhan, N B and Lahiri, Debomoy KCurrent medicinal chemistry, vol. 18, (no. 22), pp. 3306-13, 2011.
| Journal Article
The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen.Rogers, Jack T⋅Mikkilineni, Sohan⋅Cantuti-Castelvetri, Ippolita⋅Smith, Deborah H⋅Huang, Xudong⋅Bandyopadhyay, Sanghamitra⋅Cahill, Catherine M⋅Maccecchini, Maria L⋅Lahiri, Debomoy K and Greig, Nigel HJournal of neural transmission (Vienna, Austria : 1996), vol. 118, (no. 3), pp. 493-507, 2011/Mar.
| Journal Article
The Alzheimer's amyloid beta -peptide (A beta ) binds a specific DNA A beta -interacting domain (A beta ID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: Characterizing a new regulatory motifMaloney, Bryan and Lahiri, Debomoy KGene, vol. 488, (no. 1-2), pp. 1-12, 2011.
| Journal Article
The Alzheimer's amyloid β-peptide (Aβ) binds a specific DNA Aβ-interacting domain (AβID) in the APP, BACE1, and APOE promoters in a sequence-specific manner: characterizing a new regulatory motif.Maloney, Bryan and Lahiri, Debomoy KGene, vol. 488, (no. 1-2), pp. 1-12, 2011/Nov/15.
| Journal Article
2010
A novel effect of rivastigmine on pre-synaptic proteins and neuronal viability in a neurodegeneration model of fetal rat primary cortical cultures and its implication in Alzheimer's disease.Bailey, Jason A and Lahiri, Debomoy KJournal of neurochemistry, vol. 112, (no. 4), pp. 843-853, February 2010.
| Journal Article
Beyond the signaling effect role of amyloid-b sub(42) on the processing of APP, and its clinical implicationsLahiri, Debomoy K and Maloney, BryanExperimental Neurology, vol. 225, (no. 1), pp. 51-54, 2010.
| Journal Article
Beyond the signaling effect role of amyloid-ß42 on the processing of APP, and its clinical implications.Lahiri, Debomoy K and Maloney, BryanExperimental neurology, vol. 225, (no. 1), pp. 51-4, 2010/Sep.
| Journal Article
Coming to grips with complex disorders: genetic risk prediction in bipolar disorder using panels of genes identified through convergent functional genomics.Patel, S D⋅Le-Niculescu, H⋅Koller, Daniel⋅Green, S D⋅Lahiri, Debomoy K⋅Mc Mahon, Francis J⋅Nurnberger, John I and Niculescu, Alexander BAmerican journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, vol. 153B, (no. 4), pp. 850-77, 2010/Jun/5.
| Journal Article
Coming to grips with complex disorders: Genetic risk prediction in bipolar disorder using panels of genes identified through convergent functional genomicsPatel, S. D⋅Le-Niculescu, H.⋅Koller, Daniel⋅Green, S. D⋅Lahiri, Debomoy K⋅Mc Mahon, Francis J⋅Nurnberger, John I and Niculescu, Alexander BAmerican Journal of Medical Genetics. Part B: Neuropsychiatric Genetics, vol. 153B, (no. 4), pp. 850-877, 2010.
| Journal Article
Current Aging Science: Editorial ["Current Aging Science": An Important Platform for Reporting Advances in Aging-related Research]Lahiri, DebomoyCurrent Aging Science, vol. 3, (no. 1), pp. 2, 2010-February.
| Journal Article
Current Alzheimer Research: Editorial ['Current Alzheimer Research' Helps Accelerate the Progress of the Field]Lahiri, DebomoyCurrent Alzheimer Research, vol. 7, (no. 1), pp. 2, 2010-February.
| Journal Article
'Current Alzheimer research' helps accelerate the progress of the field.Lahiri, Debomoy KCurrent Alzheimer research, vol. 7, (no. 1), pp. 1-2, 2010/Feb.
| Journal Article
Editorial ['Current Alzheimer Research' Helps Accelerate the Progress of the Field]Lahiri, DebomoyCurrent Alzheimer Research, vol. 7, (no. 1), pp. 2, 2010-02-01.
| Journal Article
Functional characterization of three single-nucleotide polymorphisms present in the human APOE promoter sequence: Differential effects in neuronal cells and on DNA-protein interactionsMaloney, Bryan⋅Ge, Yuan-Wen⋅Petersen, Ronald C⋅Hardy, John⋅Rogers, Jack T⋅Perez-Tur, Jordi⋅Pérez-Tur, Jordi and Lahiri, Debomoy KAmerican Journal of Medical Genetics. Part B: Neuropsychiatric Genetics, vol. 153B, (no. 1), pp. 185-201, 2010.
| Journal Article
Functional characterization of three single-nucleotide polymorphisms present in the human APOE promoter sequence: Differential effects in neuronal cells and on DNA-protein interactions.Maloney, Bryan⋅Ge, Yuan-Wen⋅Petersen, Ronald C⋅Hardy, John⋅Rogers, Jack T⋅Pérez-Tur, Jordi and Lahiri, Debomoy KAmerican journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics, vol. 153B, (no. 1), pp. 185-201, 2010/Jan/5.
| Journal Article
GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.Li, Yazhou⋅Duffy, Kara B⋅Ottinger, Mary A⋅Ray, Balmiki⋅Bailey, Jason A⋅Holloway, Harold W⋅Tweedie, David⋅Perry, Tracyann⋅Mattson, Mark P⋅Kapogiannis, Dimitrios⋅Sambamurti, Kumar⋅Lahiri, Debomoy K and Greig, Nigel HJournal of Alzheimer's disease : JAD, vol. 19, (no. 4), pp. 1205-19, 2010.
| Journal Article
Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine.Yu, Qian-Sheng⋅Holloway, Harold W⋅Luo, Weiming⋅Lahiri, Debomoy K⋅Brossi, Arnold and Greig, Nigel HBioorganic & medicinal chemistry, vol. 18, (no. 13), pp. 4687-93, 2010/Jul/1.
| Journal Article
Melatonin Alters Age-Related Changes in Transcription Factors and Kinase ActivationBondy, Stephen C⋅Li, Huihui⋅Zhou, Jun⋅Wu, Meixia⋅Bailey, Jason A and Lahiri, Debomoy KNeurochemical Research, vol. 35, (no. 12), pp. 2035-2042, 2010.
| Journal Article
Memantine lowers amyloid- beta peptide levels in neuronal cultures and in APP/PS1 transgenic miceAlley, George M⋅Bailey, Jason A⋅Chen, DeMao⋅Ray, Balmiki⋅Puli, Lakshman K⋅Tanila, Heikki⋅Banerjee, Pradeep K and Lahiri, Debomoy KJournal of Neuroscience Research, vol. 88, (no. 1), pp. 143-154, 2010.
| Journal Article
Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP/PS1 transgenic mice.Alley, George M⋅Bailey, Jason A⋅Chen, Demao⋅Ray, Balmiki⋅Puli, Lakshman K⋅Tanila, Heikki⋅Banerjee, Pradeep K and Lahiri, Debomoy KJournal of neuroscience research, vol. 88, (no. 1), pp. 143-154, January 2010.
| Journal Article
Memantine treatment decreases levels of secreted Alzheimer's amyloid precursor protein (APP) and amyloid beta (A beta ) peptide in the human neuroblastoma cellsRay, Balmiki⋅Banerjee, Pradeep K⋅Greig, Nigel H and Lahiri, Debomoy KNeuroscience Letters, vol. 470, (no. 1), pp. 1-5, 2010.
| Journal Article
Novel drug targets based on metallobiology of Alzheimer's diseaseBandyopadhyay, Sanghamitra⋅Huang, Xudong⋅Lahiri, Debomoy K and Rogers, Jack TExpert Opinion on Therapeutic Targets, vol. 14, (no. 11), pp. 1177-1197, 2010.
| Journal Article
Novel Specific MicroRNAs in Regulating Neuronal Genes Implicated In Alzheimer's DiseaseLong, Justin and Lahiri, DebomoyAlzheimer's & Dementia: The Journal of the Alzheimer's Association, vol. 6, (no. 4), pp. e13, 2010.
| Journal Article
P3‐438: The effect of memantine and rivastigmine on synaptic markers and amyloid processing in cell culture and animal models of Alzheimer's diseaseLahiri, Debomoy K⋅Bailey, Jason A⋅Ray, Balmiki⋅Tanila, Heikki⋅Banerjee, Pradeep and Long, JustinAlzheimer's & Dementia, vol. 6, pp. S582, July 2010.
| Journal Article